Cargando…
MicroRNA‐155‐3p promotes glioma progression and temozolomide resistance by targeting Six1
The prognosis of glioma is generally poor and is the cause of primary malignancy in the brain. The role of microRNAs has been implicated in tumour inhibition or activation. In several cancers, the Six1 signalling pathway has been found to be aberrant and also relates to the formation of tumours. We...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205810/ https://www.ncbi.nlm.nih.gov/pubmed/32220051 http://dx.doi.org/10.1111/jcmm.15192 |